Search

Your search keyword '"Go R"' showing total 916 results

Search Constraints

Start Over You searched for: Author "Go R" Remove constraint Author: "Go R"
916 results on '"Go R"'

Search Results

304. Erratum for ‘Room-temperature continuous-wave operation of long wavelength (λ=9.5 µm) MOVPE-grown quantum cascade lasers’.

306. Comparison of measures of marker informativeness for ancestry and admixture mapping

307. Database mining for selection of SNP markers useful in admixture mapping

309. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?

310. Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama

316. Fruit Morphology of Durio zibethinus L. in Jelebu, Negeri Sembilan, Malaysia.

319. 5.6 µm quantum cascade lasers based on a two-material active region composition with a room temperature wall-plug efficiency exceeding 28.

320. Digitalized herbaria data for assessing extinction risk of the endemic vandaceous orchids of Peninsular Malaysia.

321. Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis.

322. Enhancement of protease production by the optimization of Bacillus subtilis culture medium

323. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

325. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

326. Continuous wave operation of quantum cascade lasers with frequency-shifted feedback.

327. External cavity quantum cascade lasers with ultra rapid acousto-optic tuning.

328. Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma.

329. Persistent infection with neurotropic herpes viruses and cognitive impairment.

330. A polymorphism in SOD2 is associated with development of Alzheimer’s disease.

331. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status:A report from an international DLBCL rituximab-CHOP consortium program study

332. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

333. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy:a report from the international DLBCL rituximab-CHOP consortium program

334. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures:a report from The International DLBCL Rituximab-CHOP Consortium Program

335. Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

336. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

338. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP:report from an International DLBCL Rituximab-CHOP Consortium Program Study

339. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Catalog

Books, media, physical & digital resources